ANAVEX LIFE SCIENCES CORP. — Director's Dealing 2025

Jan 18, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK: 0001314052
Period of Report: 2025-01-15

Reporting Person: Boenisch Sandra (PFO & Treasurer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-15	Stock Option (Right to Buy)	$8.57	A	12500	Acquired	2033-03-31	Common Stock (12500)	Direct

Footnotes

F1: On March 31, 2023, the reporting person was granted an option to purchase 50,000 shares of common stock. The option vests in four equal tranches based on four performance milestones, one of which was Publication of AD-004 Alzheimer's disease study. The performance criteria for this milestone was met, resulting in vesting of the option as to 12,500 shares.